CR BOYA-BIO Stock Code: 300294 Stock Abbreviation: Boya Bio Announcement No.: 2026-024 CR Pharma Group Co., Ltd. Announcement of Resolutions of the 20th Meeting of the 8th Board of Directors The Company and all members of the Board of Directors guarantee the authenticity, accuracy, and completeness of the announcement, and that there are no false records, misleading statements, or major omissions.
I. Convening of the Board Meeting
The 20th meeting of the 8th Board of Directors of CR Pharma Group Co., Ltd. (hereinafter referred to as the Company) was notified by email and telephone on April 17, 2026, and held on April 23, 2026, in the Company's meeting room through on-site and teleconference voting. Ten directors were expected to attend, and ten directors actually attended. The meeting was presided over by Chairman Mr. Qiu Kai, and senior management personnel of the Company were present. This meeting complied with the "Company Law of the People's Republic of China," the "Securities Law of the People's Republic of China," the "Listing Rules of the Shenzhen Stock Exchange for GEM Companies," the "Shenzhen Stock Exchange GEM Listed Company Self-Regulatory Guidelines No. 2 - Standardized Operation of GEM Listed Companies," and the "Articles of Association" and other relevant regulations. After full discussion, the following proposals were deliberated and approved.
II. Deliberation of the Board Meeting